Analysts have recently evaluated GoodRx Holdings and provided 12-month price targets. The average target is $4.16, accompanied by a high estimate of $6.00 and a low estimate of $2.75. This current ...
Prescription savings company GoodRx launched an initiative April 27 in which patients can find, apply for and claim Sanofi discounts directly on GoodRx’s platform. On GoodRx’s website, users can ...
Downgrading GoodRx to a sell rating on recent decline fundamentals. GoodRx's revenue growth is decelerating, with significant reliance on retail partnerships and cyclical transactional revenue, making ...
GoodRx, a health tech startup that helps the uninsured buy medications at lower costs, is looking to sell itself for anywhere between $1.5 billion and $3 billion, sources told CNBC. The company isn’t ...
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on GoodRx Holdings (NASDAQ:GDRX) in the last three months. The following table encapsulates their ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results